PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Studies: Current hepatitis C treatments can't be used by more than half of patients; others lose opportunity for treatment

2013-10-31
(Press-News.org) Contact information: Dwight Angell
dwight.angell@hfhs.org
313-850-3471
Henry Ford Health System
Studies: Current hepatitis C treatments can't be used by more than half of patients; others lose opportunity for treatment DETROIT – More than half of chronic hepatitis C patients studied in a new research project led by Henry Ford Hospital were not treated for the potentially fatal disease, either because they couldn't withstand current therapies or because they, or their doctors, were waiting for new treatments. In a second, related study, Henry Ford researchers found that while the disease is not yet curable, there is a significant "lost opportunity" for hepatitis C patients to achieve the current best result of treatment. Both studies are being presented at the annual meeting of the American Association for the Study of Liver Diseases being held in Washington, DC, Nov. 1-5. Stuart C. Gordon, M.D., director of the Hepatology section at Henry Ford, and lead author of the first study, said it was launched because of a lack of information about the subject. "Limited data exist concerning the clinical disposition of U.S. patients with chronic hepatitis C infection, including the reasons for lack of antiviral treatment," Dr. Gordon says. "Our goal was to add to that data." The team collected electronic health records from four large American health systems of patients with confirmed chronic hepatitis C, a viral infection that progressively scars the liver and eventually destroys the organ and its vital functions. Of these 4,271 patients diagnosed with the infection and still alive through the end of 2011, the median age was 57; 57 percent were male; 29 percent were black and 97 percent were insured. 543, or 12.7 percent, had previously achieved a sustained virologic response (SVR), meaning the hepatitis C virus was suppressed to the point that it could no longer be detected in their blood for six months after anti-viral treatment. 110, or 2.6 percent, were currently on anti-viral therapy. Of the remaining 3,618 patients, 12 percent had never been followed up within the health care system, despite clinical confirmation that they had chronic hepatitis C. The majority, 55 percent, were not being treated, either because of "absolute contraindications" to current therapy – meaning the risk of available treatment is too high – or because either the patient or physician were waiting for newer therapies. Another 12 percent of patients had chosen not to start treatment, despite a doctor's recommendation to do so. "These results confirm that only a small proportion of chronic hepatitis C patients in American health care systems who were still being followed at the end of 2011 had achieved an SVR with available antiviral regimens," Dr. Gordon said. The second study sought to identify "lost opportunities" to treat hepatitis C patients and achieve SVR, now the closest thing to a "cure" for the disease. "We looked at data regarding testing for chronic Hep C, patient referral, patient visits and the start of treatment," explains Kimberly Ann Brown, M.D., division head of Gastroenterology at Henry Ford Hospital and lead author of the study's findings. "In addition," Dr. Brown says, "we considered patient age, race, gender, income, marital status, psychiatric diagnoses and the number of comorbidities, or co-existing diseases." The findings showed that of the 458 patients identified with a positive hepatitis C antibody, only 117 received confirmatory testing, were referred to a specialist and presented to the office for a visit. Of the 117 patients who came for the specialty visit, only 21, or 17.9 percent, were felt to be appropriate treatment candidates. "This data speaks to the significant "lost opportunity" we have, not only in identifying patients with hepatitis C in our community, but also in providing them with appropriate treatment options," says Dr. Brown.

### END


ELSE PRESS RELEASES FROM THIS DATE:

HIV antibody infusions show promise for treating SHIV-infected monkeys

2013-10-31
HIV antibody infusions show promise for treating SHIV-infected monkeys NIH-supported scientists advocate trying similar strategy in people WHAT: Two teams are reporting results from experiments in which they infused powerful ...

Study: Fast, painless alternative to liver biopsies for hepatitis patients proves accurate and reliable

2013-10-31
Study: Fast, painless alternative to liver biopsies for hepatitis patients proves accurate and reliable DETROIT – A non-invasive alternative to liver biopsy, now the standard method of diagnosing cirrhosis in hepatitis patients, proved very reliable in a national ...

Gaming technology unravels 1 of the most complex entities in nature

2013-10-31
Gaming technology unravels 1 of the most complex entities in nature Computational research unveils secrets in the human carbohydrate bar-code BBSRC-funded researchers at the University of Manchester's Institute of Biotechnology have ...

The secret's in the (robotic) stroke

2013-10-31
The secret's in the (robotic) stroke NYU-Poly researchers tease out cues that impact schooling fish behavior Brooklyn, New York— Recent studies from two research teams at the Polytechnic Institute of New York University (NYU-Poly) demonstrate ...

Increasing rate of knee replacements linked to obesity among young, researchers say

2013-10-31
Increasing rate of knee replacements linked to obesity among young, researchers say New data show younger adults have same or greater impairment than older patients BOSTON – Contrary to popular myth, it is not the aging Baby Boomer or weekend ...

Newly identified proteins make promising targets for blocking graft-vs.-host disease

2013-10-31
Newly identified proteins make promising targets for blocking graft-vs.-host disease Finding could help improve outcomes from bone marrow transplants ANN ARBOR, Mich. — Researchers from the University of Michigan Comprehensive Cancer Center have ...

Biochemists find incomplete protein digestion is a useful thing for some bacteria

2013-10-31
Biochemists find incomplete protein digestion is a useful thing for some bacteria To the authors' surprise, 1 specialized replication factor was partially digested or trimmed, physically cut into shorter fragments, by an energy-dependent protease ...

Long-term use of prescription-based painkillers increases the risk of depression, SLU researcher finds

2013-10-31
Long-term use of prescription-based painkillers increases the risk of depression, SLU researcher finds ST. LOUIS – Opioid analgesics, or prescription-based narcotic pain killers, have long been known to reduce pain, but reports of adverse effects and addiction continue ...

Houston we have a problem: Microgravity accelerates biological aging

2013-10-31
Houston we have a problem: Microgravity accelerates biological aging New research in The FASEB Journal suggests that gravitational unloading significantly impairs the function of endothelial cells, as evidenced by gene expression ...

Primary GOES-R instrument ready to be installed onto spacecraft

2013-10-31
Primary GOES-R instrument ready to be installed onto spacecraft A key instrument that will fly on the Geostationary Operational Environmental Satellite – R (GOES-R) spacecraft, NOAA's next-generation of geostationary satellites, is cleared for installation ...

LAST 30 PRESS RELEASES:

An electronic fiber for stretchable sensing

New image captures spooky bat signal in the sky

Cobalt single atom-phosphate functionalized reduced graphene oxide/perylenetetracarboxylic acid nanosheet heterojunctions for efficiently photocatalytic H2O2 production

World-first study shows Australian marsupials contaminated with harmful ‘forever chemicals’

Unlocking the brain’s hidden drainage system

Enhancing smoking cessation treatment for people living with HIV

Research spotlight: Mapping how gut neurons respond to bacteria, parasites and food allergy

Gordon and Betty Moore Foundation Experimental Physics Investigators awards to UCSB experimentalists opens the door to new insights and innovations

Meerkats get health benefit from mob membership

COVID-19 during pregnancy linked to higher risk of neurodevelopmental disorders in children

How a chorus of synchronized frequencies helps you digest your food

UAlbany researcher partners on $1.2 million NSF grant to explore tropical monsoon rainfall patterns

Checkup time for Fido? Wait might be longer in the country

Genetic variation impact scores: A new tool for earlier heart disease detection

The Lundquist Institute awarded $9 million to launch Community Center of Excellence for Regenerative Medicine

'Really bizarre and exciting': The quantum oscillations are coming from inside

Is AI becoming selfish?

New molten salt method gives old lithium batteries a second life

Leg, foot amputations increased 65% in Illinois hospitals between 2016-2023

Moffitt studies uncover complementary strategies to overcome resistance to KRAS G12Cinhibitors in lung cancer

National summit of experts charts unprecedented roadmap to reduce harms from firearms in new ways

Global environmental DNA (eDNA) surveys significantly expand known geographic and ecological niche ranges of marine fish, highlighting current biases in conservation and ecological modeling

Hundreds of animal studies on brain damage after stroke flagged for problematic images

Prize winner’s research reveals how complex neural circuits are correctly wired during brain development

Supershear rupture sustained in thick fault zone during 2025 Mandalay earthquake, study in research package shows

Study reveals how brain cell networks stabilize memory formation

CTE: More than just head trauma, suggests new study

New psychology study suggests chimpanzees might be rational thinkers

Study links genetic variants to higher 'bad' cholesterol and heart attack risk

Myanmar fault had ideal geometry to produce 2025 supershear earthquake

[Press-News.org] Studies: Current hepatitis C treatments can't be used by more than half of patients; others lose opportunity for treatment